Cardiac Resynchronization Therapy (CRT) stands at the forefront of advanced cardiac interventions, offering a targeted solution for individuals grappling with heart failure. This sophisticated therapy involves the implantation of a specialized device, often a pacemaker, with the aim of harmonizing the contractions of the heart's ventricles. By precisely orchestrating these contractions, CRT addresses the synchronization challenges that often accompany heart failure, ultimately boosting the heart's efficiency. Through the optimized timing of electrical impulses, CRT enhances the heart's pumping capability, resulting in improved blood flow and overall cardiovascular function. The transformative impact of CRT is evident in its ability to alleviate symptoms, enhance exercise tolerance, and elevate the overall quality of life for many patients. This therapeutic approach continues to redefine the landscape of cardiac care, offering hope and improved outcomes for individuals navigating the complexities of heart failure.
Title : Personalized and precision medicine (PPM) as a unique healthcare model through biodesign-driven translational applications and cardiology-related healthcare marketing to secure the human healthcare and biosafety
Sergey Suchkov, N.D. Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences, Russian Federation
Title : Beyond weight loss and diabetes control GLP 1 agonists paradigm shift in Cardiovascular care .
Syed Raza, Awali Hospital, Bahrain
Title : Vericiguat Inhibits the Progress of Cardiac Hypertrophy and Prevents Hypertrophy Induced Heart Failure by Multiple Mechanisms
Guo Wei He, TEDA International Cardiovascular Hospital, Tianjin University, China
Title : Coronary revascularization in patients with diabetes: Prospects for stenting in patients with type 1 diabetes and coronary artery disease
Mekhman N Mamedov, National Research Center for Therapy and Preventive Medicine, Russian Federation
Title : STEMI versus acute occlusive myocardial infarction: Which term should we use?
Yochai Birnbaum, Baylor College of Medicine, United States
Title : Chronic angina and the health economics of cardiovascular risk reduction in macro- and microvascular coronary disease
Uwe Peter Tigor, Auxilius Pharma, United States